A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.
Clinical trial NCT06733337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06733337
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-11
- Primary completion
- 2029-06-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.